KolmarBNH Co Ltd
KOSDAQ:200130
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11 650
18 990
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
KolmarBNH Co Ltd
Cash Equivalents
KolmarBNH Co Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KolmarBNH Co Ltd
KOSDAQ:200130
|
Cash Equivalents
₩20.6B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Cash Equivalents
₩493.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
Amorepacific Group
KRX:002790
|
Cash Equivalents
₩616.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
3%
|
|
|
Cosmax Inc
KRX:192820
|
Cash Equivalents
₩205.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cash Equivalents
₩745.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cash Equivalents
₩21.9B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
4%
|
|
KolmarBNH Co Ltd
Glance View
KolmarBNH Co., Ltd. engages in the provision of manufacturing medicaments. The company is headquartered in Sejong, Sejong. The company went IPO on 2014-07-23. The firm mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The firm also produces cosmetics using natural extracts, and other pharmaceuticals. The firm also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
See Also
What is KolmarBNH Co Ltd's Cash Equivalents?
Cash Equivalents
20.6B
KRW
Based on the financial report for Sep 30, 2024, KolmarBNH Co Ltd's Cash Equivalents amounts to 20.6B KRW.
What is KolmarBNH Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-16%
Over the last year, the Cash Equivalents growth was -12%. The average annual Cash Equivalents growth rates for KolmarBNH Co Ltd have been -36% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
